Published in Am J Kidney Dis on April 01, 2003
Association between serum aspartate transaminase and homocysteine levels in hemodialysis patients. Am J Kidney Dis (2002) 1.43
Testing for recombinant human erythropoietin. J Appl Physiol (1985) (2008) 3.02
Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta (2006) 2.97
False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise. Blood (2006) 2.06
Assessment of renal function in recently admitted critically ill patients with normal serum creatinine. Nephrol Dial Transplant (2005) 1.72
Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old. J Am Geriatr Soc (2002) 1.68
Development of an affordable dye-stained microalbuminuria screening test. Nephrol Dial Transplant (2008) 1.50
Faecal leukocyte esterase activity is an alternative biomarker in inflammatory bowel disease. Clin Chem Lab Med (2015) 1.41
Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. Clin Chim Acta (2008) 1.23
Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma. Am J Respir Crit Care Med (2010) 1.14
Diagnostic value of the hemopexin N-glycan profile in hepatocellular carcinoma patients. Clin Chem (2010) 1.09
Prohepcidin accumulates in renal insufficiency. Clin Chem Lab Med (2004) 1.09
Alpha 1-microglobulin: clinical laboratory aspects and applications. Clin Chim Acta (2004) 1.08
Tumor necrosis factor receptors: biology and therapeutic potential in kidney diseases. Am J Nephrol (2012) 1.05
Analytical interferences in point-of-care testing glucometers by icodextrin and its metabolites: an overview. Perit Dial Int (2009) 1.05
Increased urinary neutrophil gelatinase associated lipocalin in urinary tract infections and leukocyturia. Clin Chem Lab Med (2011) 1.05
Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma. J Thorac Oncol (2011) 1.00
Flow cytometry as a new method to quantify the cellular content of human saliva and its relation to gingivitis. Clin Chim Acta (2002) 0.97
Haptoglobin polymorphism and lacunar stroke. Curr Neurovasc Res (2008) 0.96
Haptoglobin polymorphism and infection. Adv Clin Chem (2010) 0.95
Critical evaluation of connectivity-based point of care testing systems of glucose in a hospital environment. Clin Chem Lab Med (2008) 0.94
Reevaluation of formulas for predicting creatinine clearance in adults and children, using compensated creatinine methods. Clin Chem (2003) 0.94
Quantitative evaluation of urinalysis test strips. Clin Chem (2002) 0.92
Haptoglobin polymorphism in patients with preeclampsia. Clin Chem Lab Med (2006) 0.92
Glycosylation of prostate specific antigen and its potential diagnostic applications. Clin Chim Acta (2012) 0.91
The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factor. Chest (2011) 0.90
Calibration and precision of serum creatinine and plasma cystatin C measurement: impact on the estimation of glomerular filtration rate. J Nephrol (2014) 0.89
Non-oxidative ethanol metabolites as a measure of alcohol intake. Clin Chim Acta (2012) 0.89
Vitamin D binding protein, bone status and body composition in community-dwelling elderly men. Bone (2005) 0.89
A genome-wide association study identifies rs2000999 as a strong genetic determinant of circulating haptoglobin levels. PLoS One (2012) 0.89
Biological and clinical aspects of soluble transferrin receptor. Crit Rev Clin Lab Sci (2010) 0.88
Glycated nail proteins: a new approach for detecting diabetes in developing countries. Trop Med Int Health (2013) 0.88
Biologically active, magnICON®-expressed EPO-Fc from stably transformed Nicotiana benthamiana plants presenting tetra-antennary N-glycan structures. J Biotechnol (2012) 0.87
Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort study. J Thorac Oncol (2011) 0.86
Serum free hemoglobin concentrations in healthy individuals are related to haptoglobin type. Clin Chem (2005) 0.86
Vitamin D binding protein: a multifunctional protein of clinical importance. Adv Clin Chem (2014) 0.86
Vitamin D binding protein, a new nutritional marker in cystic fibrosis patients. Clin Chem Lab Med (2008) 0.85
Quantitative determination of vigabatrin and gabapentin in human serum by gas chromatography-mass spectrometry. Clin Chim Acta (2005) 0.85
Serum vitamin C concentration is influenced by haptoglobin polymorphism and iron status in Chinese. Clin Chim Acta (2005) 0.85
Studies on dialysate mixing in the Genius single-pass batch system for hemodialysis therapy. Kidney Int (2003) 0.85
Urinary beta-trace protein as a new renal tubular marker. Clin Chem (2009) 0.84
Evaluation of Sysmex UF-1000i for use in cerebrospinal fluid analysis. Clin Chim Acta (2008) 0.83
Automated flow cytometry analysis of peritoneal dialysis fluid. Nephrol Dial Transplant (2004) 0.83
Haptoglobin phenotype correlates with the extent of cerebral deep white matter lesions in hypertensive patients. Curr Neurovasc Res (2010) 0.83
Creatine supplementation decreases homocysteine in an animal model of uremia. Kidney Int (2003) 0.82
Chemiluminescent image detection of haptoglobin phenotyping after polyacrylamide gel electrophoresis. Anal Chem (2004) 0.82
Determination of beta2-agonists by ion chromatography with direct conductivity detection. J Pharm Biomed Anal (2005) 0.81
Proteolysis is a confounding factor in the interpretation of faecal calprotectin. Clin Chem Lab Med (2015) 0.81
Glomerular filtration rate is a confounder for the measurement of soluble mesothelin in serum. Clin Chem (2009) 0.81
Birth weight in relation to sex steroid status and body composition in young healthy male siblings. J Clin Endocrinol Metab (2010) 0.81
Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status. Nephrol Dial Transplant (2007) 0.81
Value and pitfalls in iodine fortification and supplementation in the 21st century. Br J Nutr (2011) 0.80
Human epididymis protein 4 in cancer diagnostics: a promising and reliable tumor marker. Adv Clin Chem (2013) 0.80
Java project on periodontal diseases: periodontal bone loss in relation to environmental and systemic conditions. J Clin Periodontol (2015) 0.80
Investigation of the potential association of vitamin D binding protein with lipoproteins. Ann Clin Biochem (2010) 0.80
Soluble transferrin receptor in urine, a new biomarker for IgA nephropathy and Henoch-Schönlein purpura nephritis. Clin Biochem (2013) 0.79
Unanswered questions in including HDL-cholesterol in the cardiovascular risk estimation. Is time still on our side? Atherosclerosis (2012) 0.79
Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease. J Clin Immunol (2013) 0.79
Compensating for the influence of total serum protein in the Schwartz formula. Clin Chem Lab Med (2012) 0.78
Sex hormone-binding globulin at the crossroad of body composition, somatotropic axis and insulin/glucose homeostasis in young healthy men. Clin Endocrinol (Oxf) (2012) 0.78
Use of nanomaterials in capillary and microchip electrophoresis. Expert Rev Proteomics (2007) 0.78
Iron status in black persons is not influenced by haptoglobin polymorphism. Clin Chem Lab Med (2002) 0.78
Chronic nicotine exposure and acute kidney injury: new concepts and experimental evidence. Nephrol Dial Transplant (2013) 0.78
Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients. Kidney Int (2004) 0.78
Folates from metabolically engineered rice: a long-term study in rats. Mol Nutr Food Res (2015) 0.78
Galectin-3 in Renal Pathology: More Than Just an Innocent Bystander. Am J Nephrol (2016) 0.78
Carbohydrate deficient transferrin in a driver's license regranting program. Alcohol Alcohol (2012) 0.78
Creatine supplementation does not affect kidney function in an animal model with pre-existing renal failure. Nephrol Dial Transplant (2003) 0.77
Diagnostic performance of combined specific urinary proteins and urinary flow cytometry in urinary tract pathology. Clin Chem Lab Med (2007) 0.77
Association of haptoglobin phenotypes with the development of Kaposi's sarcoma in HIV patients. Arch Dermatol Res (2011) 0.77
The haptoglobin phenotype is associated with the Epstein-Barr virus antibody titer. Clin Chem Lab Med (2009) 0.77
Direct chemiluminescent imaging detection of human serum proteins in two-dimensional polyacrylamide gel electrophoresis. Proteomics (2007) 0.77
Spuriously high thyrotropin values due to anti-thyrotropin antibodies in adult patients. Clin Chem Lab Med (2009) 0.77
Immunochemically unreactive albumin in urine: fiction or reality? Crit Rev Clin Lab Sci (2011) 0.77
Detection of antibodies in cardiac autoimmunity. Clin Chim Acta (2009) 0.76
Donor haptoglobin phenotype determines outcome following liver transplantation. Transpl Int (2011) 0.76
Determination of ephedrine and related compounds in pharmaceutical preparations by ion chromatography with direct conductivity detection. Biomed Chromatogr (2005) 0.76
Effect of dietary creatine on skeletal muscle myosin heavy chain isoform expression in an animal model of uremia. Nephron Exp Nephrol (2004) 0.76
Mesothelin levels in urine are affected by glomerular leakage and tubular reabsorption. Clin Lung Cancer (2012) 0.76
Enhanced separation of purine and pyrimidine bases using carboxylic multiwalled carbon nanotubes as additive in capillary zone electrophoresis. Electrophoresis (2006) 0.76
Agglutination of intravenously administered phosphatidylcholine-containing lipid emulsions with serum C-reactive protein. Nutr Clin Pract (2013) 0.76
On the use of dispersed nanoparticles modified with single layer beta-cyclodextrin as chiral selecor to enhance enantioseparation of clenbuterol with capillary electrophoresis. Talanta (2005) 0.75
9. GFR - Where are We Now? EJIFCC (2009) 0.75
Haptoglobin polymorphism and serum ferritin concentration in ageing subjects. Br J Haematol (2004) 0.75
Trypsin is a Potential Confounder in Calprotectin Results. J Pediatr Gastroenterol Nutr (2015) 0.75
Development of an ELISA for the determination of the major haptoglobin phenotype: an interesting technical development and its potential consequences. Clin Chem (2004) 0.75
Novel application of carbon nanotubes for improving resolution in detecting human serum proteins with native polyacrylamide gel electrophoresis. Nano Lett (2009) 0.75
Evolution of vitamin D binding protein concentration in sera from cardiac surgery patients is determined by triglyceridemia. Clin Chem Lab Med (2010) 0.75
Haptoglobin and body mass index. J Clin Endocrinol Metab (2005) 0.75
Effect of transferrin polymorphism on the metabolism of vitamin C in Zimbabwean adults. Am J Clin Nutr (2002) 0.75
Performance of urinary flow cytometry in predicting outcome of urine cultures. J Clin Microbiol (2002) 0.75
Microheterogeneity of serum β-hexosaminidase in chronic alcohol abusers in a driver's license regranting program. Alcohol Clin Exp Res (2013) 0.75
A SELDI-TOF-MS study in Lacunar Stroke with Subsequent Haptoglobin Phenotyping. Curr Neurovasc Res (2008) 0.75
Lowering methylation demand by creatine supplementation paradoxically decreases DNA methylation. Mol Genet Metab (2007) 0.75
Exercise-induced myocardial ischemia is accompanied by increased serum creatine concentrations. Clin Chem (2003) 0.75